CCA
ATEX icon

Column Capital Advisors’s Anterix ATEX Stock Holding History

Column Capital Advisors’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30
Closed -$1K – 698
2020
Q2 		$1K Hold
30
– – ﹤0.01% 713
2020
Q1 		$1K Hold
30
– – ﹤0.01% 593
2019
Q4 		$1K Buy
+30
New +$1.22K ﹤0.01% 631

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
BCC
Bain Capital Credit Boston, Massachusetts $368M AUM 9.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return

Column Capital Advisors's ATEX Position: Q3 2020 in Review

Column Capital Advisors sold out of Anterix (ATEX) in Q3 2020, closing a stake of 30 shares — an estimated $1K sold.

Column Capital Advisors first reported a position in ATEX in Q4 2019 and held it in 3 quarters. The position peaked at $1K in Q2 2020. 96 funds tracked by Wall St. Rank hold ATEX as of Q3 2020.

  • Column Capital Advisors reported no remaining Anterix position as of Q3 2020 after selling out during the quarter.
  • Column Capital Advisors sold 30 Anterix shares in Q3 2020, an estimated $1K.
  • Column Capital Advisors first reported a position in Anterix in Q4 2019 and held it in 3 quarters.
  • Column Capital Advisors's Anterix position peaked at $1K in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Anterix as of Q3 2020.

Based on Column Capital Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.